Woodline Partners’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.2M Buy
2,068,445
+253,224
+14% +$1.96M 0.07% 344
2026
Q1
$11.6M Buy
1,815,221
+847,544
+88% +$5.9M 0.04% 473
2025
Q4
$6.81M Buy
+967,677
New +$5.84M 0.03% 557
2025
Q1
Sell
-632,301
Closed -$4.66M 977
2024
Q4
$4.66M Sell
632,301
-691,089
-52% -$4.96M 0.03% 497
2024
Q3
$9.26M Buy
+1,323,390
New +$7.95M 0.08% 314
2021
Q3
Sell
-273,207
Closed -$7.61M 717
2021
Q2
$7.61M Buy
+273,207
New +$7.22M 0.14% 172

Other funds holding LFST

Woodline Partners's LFST Position: Q2 2026 in Review

Woodline Partners increased its Lifestance Health (LFST) stake by 14% in Q2 2026, buying an estimated $1.96M and bringing the position to 2,068,445 shares worth $22.2M. The position accounts for 0.07% of the portfolio, ranked #344.

Woodline Partners first reported a position in LFST in Q2 2021 and has held it in 6 quarters since. 288 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • Woodline Partners held 2,068,445 shares of Lifestance Health worth $22.2M as of Q2 2026.
  • Woodline Partners bought 253,224 Lifestance Health shares in Q2 2026, an estimated $1.96M.
  • Lifestance Health made up 0.07% of Woodline Partners's portfolio in Q2 2026, its #344 holding.
  • Woodline Partners first reported a position in Lifestance Health in Q2 2021 and has held it in 6 quarters since.
  • 288 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.